In the human epidermis, the cells most at risk for the development of cancer due to sunlight exposure are the keratinocytes. In animal models, ultraviolet-B is a complete carcinogen, capable of inducing and promoting the development of malignant cells. A key element of ultraviolet-B-induced carcinogenesis is the ability of ultraviolet-B to induce the expression of a number of cellular proteins and activate growth factor receptor tyrosine kinases, including the erbB receptor family. Keratinocytes express the erbB1 (also called EGF-R, HER1), the erbB2 (also known as neu or HER2), and the erbB3 (HER3) subtypes. In general, activation of the erbB receptor family leads to a cellular proliferative response. In certain instances, however, activation of an erbB receptor can induce di¡erentiation, cell cycle arrest, and even apoptosis. The inhibition of tyrosine kinase activity in rodent models and human skin has been shown to inhibit some ultraviolet-B response pathways. We have shown that the inhibition of erbB receptors, by both pharmaceutical and immunologic means, will inhibit ultraviolet-B-induced apoptosis in the HaCaT human keratinocyte cell line. This inhibition was speci¢c for the erbB receptor family and spe-ci¢c for ultraviolet-B-induced apoptosis. These results suggest that, in certain instances, ultraviolet-B-induced apoptotic signaling requires erbB family receptor activity.
T he e¡ects of solar radiation on the epidermis have been well documented in both humans and animal model systems (Tyrrell, 1994; de Gruijl, 1999) . These studies have determined that the risk of developing nonmelanoma skin cancer is unmistakably linked to exposure of the epidermis to the ultraviolet spectrum of solar radiation (Ziegler et al, 1994; Brash, 1997) . In humans, the presence of mutations in tumors that are speci¢cally linked to exposure to ultraviolet-B (UVB) irradiation provides evidence that sun exposure is a cause of nonmelanoma skin cancer. As these linkage studies can only be done retrospectively, it is di⁄cult to determine the progression of individual skin cancers or determine the mechanism of carcinogenesis. Therefore, in vitro systems have been invaluable in elucidating the response of human keratinocytes to UVB exposure.
Because of the di⁄culties in working with primary normal human keratinocytes (NHK), the HaCaT keratinocyte cell line has been widely used as a surrogate to examine the e¡ects of UVB on keratinocyte cultures (Boukamp et al, 1988) . HaCaT cells were derived from skin as a spontaneously immortalized cell line that still retains the ability to undergo di¡erentiation. In many ways, HaCaT cells respond to UVB exposure in a manner similar to normal keratinocytes (Henseleit et al, 1996; 1997; Petit-Frere et al, 2000) . For example, both normal keratinocytes and HaCaT cells undergo UVB-induced apoptosis in a time-and dose-dependent manner. HaCaT cells also secrete various cytokines following UVB irradiation, again similar to normal keratinocytes (Petit-Frere et al, 2000) . Therefore, it is appropriate to use HaCaT cells as a model for the response of human keratinocytes to UVB irradiation.
Over the past several years, it has become apparent that a major factor controlling the response of keratinocytes to UVB exposure is the receptor for epidermal growth factor (EGFr) (Bender et al, 1997; Jost et al, 2000; Peus et al, 2000) . Activation of this receptor has been linked to continued cell proliferation in cell culture and the survival of keratinocytes following UVB irradiation (Peus et al, 2000; Jost et al, 2001b) . Interestingly, irradiation of keratinocytes with UVB leads to the ligand-independent activation of EGFr (Sachsenmaier et al, 1994; Huang et al, 1996) . The EGFr is but one member of a family of type I tyrosine kinase receptors, however, that share extensive amino acid homology (Jost et al, 2000; Olayioye et al, 2000; Bogdan and Klambt, 2001; Yarden and Sliwkowski, 2001) . Currently, four members of the erbB receptor family have been described: erbB1 (the EGFr), erbB2, erbB3, and erbB4. Recently, studies examining the expression and function of these receptors in the skin have been initiated. Several investigators have reported that normal skin, primary human keratinocytes, and HaCaT cells all express the erbB1, erbB2, and erbB3 receptors (Marques et al, 1999; de Potter et al, 2001; Stoll et al, 2001) . Weak expression of erbB4 has also been described from all of these sources (Marques et al, 1999) . It is unclear, however, what the functional consequences of di¡erential erbB family member activation on UVB-induced responses are. For example, UVB irradiation leads to the activation of the erbB2 receptor in a manner similar to the erbB1, but the details describing this activation have not been described (Huang et al, 1996) . Therefore, the objective of these studies was to examine the response of human keratinocytes to UVB irradiation following the inhibition of the erbB receptor family of tyrosine kinases. Our ¢ndings demonstrate that the inhibition of erbB receptors in HaCaT cells leads to a protection from UVB-induced apoptosis.
MATERIALS AND METHODS
Reagents Pharmacologic inhibitors AG 825 (4 -hydroxy-3 -methoxy-5-(benzothiazolylthiomethyl)-benzylidenecyanoacetamide), AG 1295 (6,7-dimethyl-2-phenylquinoxaline), AG 1478 (4 -(3 -chloroanilino)-6,7dimethoxyquinazoline), and neutralizing antibodies to erbB1 (clone 528) and erbB2 (clone 9G6) were all obtained from Calbiochem, La Jolla, CA. 4,5-Dianilinophthalimide (DAPH) was obtained from Sigma, St. Louis, MO. All other chemicals were obtained from Sigma or Roche Molecular Biochemicals, Indianapolis, IN.
HaCaT cell culture HaCaT keratinocyte cells were grown in Dulbecco's modi¢ed Eagle's medium (Irvine Scienti¢c, Santa Ana, CA) supplemented with 10% fetal bovine serum (Nova-Tech, Grand Island, NY) and 1000 U penicillin, streptomycin (Roche). Cells were grown to approximately 80% con£uence before experiments were carried out.
UVB irradiation UVB irradiation of HaCaT cells was accomplished using a Philips F20T12/UV-B source (270^390 nm; containing 2.6% UVC, 43.6% UVB, 53.8% UVA). The intensity of the UVB source was measured prior to each experiment using an IL1700 radiometer and an SED240 UVB detector (International Light, Newburyport, MA) at a distance of 8 cm from the UVB source to the monolayer of cells. HaCaT cells were irradiated in phosphate-bu¡ered saline, after which the original medium, with or without supplements, was returned to each culture dish.
Caspase 3 assay Caspase 3 proteolytic activity was measured in HaCaT cell lysates using a synthetic £uorogenic substrate (DEVD-AMC, Alexis Biochemicals, San Diego, CA) as previously described (Nicholson et al, 1995; Hurwitz and Spandau, 2000) . Brie£y, the HaCaT cell pellet was suspended in lysis bu¡er [50 mM PIPES pH 7.0, 50 mM KCl, 5 mM ethyleneglycol-bis(b-aminoethyl ether)-N,N,N 0 ,N 0 -tetraacetic acid, 2 mM MgCl 2 , 1 mM dithiothreitol (DTT)], subjected to one freezeÀthaw cycle, and placed on ice. Any cellular debris was removed by centrifugation. An aliquot of the cell lysate was added to caspase 3 reaction bu¡er (100 mM HEPES, pH 7.5, 10% sucrose, 0.1% CHAPS, 10 mM DTT, 0.1 mg per ml bovine albumin, and 50 mM CPP32-AMC substrate) and incubated at 371C for 1 h. Release of the £uorescent 7-amino-4 -methylcoumarin (AMC) moiety was measured using a Hitachi F2000 spectrophotometer (excitation, 380 nm; emission, 460 nm). The £uorescent intensity was converted to picomoles of AMC by comparison with the £uorescent intensity of standards of AMC (Molecular Probes, Eugene, OR). The speci¢c activity of caspase 3 in cell lysates was then determined after the total protein concentration of the cell lysates was measured (Protein Assay Reagent, Bio-Rad, Hercules, CA). Relative activities were determined by comparing the speci¢c activities derived from UVB-treated cell lysates with those derived from untreated cell lysates.
erbB tyrosine phosphorylation Activation of erbB receptor family was assayed from HaCaT cell lysates. Brie£y, HaCaT cells were washed twice with ice-cold phosphate-bu¡ered saline and lysed in RIPA bu¡er [150 mM NaCl, 50 mM TrisÀHCl, pH 8.0, 0.1% sodium dodecyl sulfate (SDS), 0.5% sodium deoxycholate, 1% Nonidet P-40] containing complete protease inhibitor cocktail (Roche), 10 mM sodium orthovanadate, and 5 mM sodium £uoride for 20 min on ice. The cell lysates were then harvested from the culture dishes and cellular debris was removed by centrifugation. Tyrosine phosphorylation of the erbB receptors was determined by immunoblotting with antiphosphotyrosine horseradish peroxidase (HRP) conjugated antibody Ab-4 (Oncogene, Boston, MA). Proteins were detected using the ECL-Plus chemiluminescence kit (Amersham Pharmacia Biotech, Buckinghamshire, U.K.). To identify total erbB1 receptors, the same immunoblot was stripped of antiphosphotyrosine-HRP antibodies with Western strip bu¡er (0.5 M TrisÀHCl, pH 6.8; 10% SDS; 100 mM b-mercaptoethanol) and re-probed with anti-erbB1 antibody (Cell Signaling Tech, Beverly, MA).
RESULTS

Time and dose dependence of UVB-induced apoptosis in
HaCaT cells The response of HaCaT cells to UVB irradiation has been extensively studied. Various investigators have shown that HaCaT cells undergo apoptosis following UVB irradiation in a time-and dose-dependent manner. Unfortunately, the actual dose of UVB required to induce apoptosis varies with each report depending on the methodology of irradiation used and the methods used to detect apoptosis. For that reason, it is important to de¢ne the response of HaCaT cells to UVB in these experiments. We have assessed the induction of apoptosis using an assay that measures the activity of the caspase 3 enzyme. Previous data from our laboratory have shown that the induction of caspase 3 perfectly correlates with the induction of other measures of apoptosis (Barber et al, 1998; Kuhn et al, 1999; Kumar et al, 1999; Marques et al, 2002) . Using the protocol described in Materials and Methods, apoptosis is induced in HaCaT cells in response to doses of UVB as low as 100 J per m 2 ( Fig 1A) when measured at 9 h post-irradiation. The response of HaCaT cells to UVB plateaus between 300 and 500 J per m 2 , so that increasing the dose of UVB beyond these levels does not result in any higher induction of apoptosis. When HaCaT cells are irradiated with a UVB dose of 400 J per m 2 , the peak time for the measurement of caspase 3 activity is between 8 and 10 h following UVB exposure ( Fig 1B) . Therefore, in all of the studies described below, HaCaT cells were irradiated with a dose of 400 J per m 2 and harvested at 9 h post-UVB irradiation.
Pharmaceutical inhibition of erbB family members suppresses the induction of apoptosis by UVB Previous studies have demonstrated that the erbB1 receptor provides a protective function from UVB-induced apoptosis. Inhibition of the erbB1 receptor using high-a⁄nity, speci¢c inhibitors resulted in increased sensitivity of UVB-induced apoptosis (Stoll et al, 1998; Peus et al, 2000; Jost et al, 2001a) . Because the erbB1 receptor is not the only erbB family member that becomes HaCaT cells were irradiated with UVB as described in Materials and Methods using the doses indicated in the ¢gure (A) or at 400 J per m 2 for the various times listed (B). For (A), the cells were harvested and assayed for caspase 3 enzyme activity at 9 h following irradiation. activated in response to UVB irradiation (Jost et al, 2000; Olayioye et al, 2000; Bogdan and Klambt, 2001; Yarden and Sliwkowski, 2001) , we used an inhibitor of both erbB1 and erbB2 receptors (DAPH) and assayed for the in£uence of both receptors on the sensitivity of HaCaT cells to UVB (Noonberg and Benz, 2000) . HaCaT cells were irradiated with a dose of 0 or 400 J per m 2 of UVB, and then treated with increasing concentrations of DAPH. By treating the cells in this manner, the e¡ectiveness of DAPH will not be a¡ected by UVB exposure, nor will DAPH directly in£uence the e¡ective dose of UVB delivered to the cells. Nine hours following 400 J per m 2 of UVB, plates of untreated HaCaT cells contained many apoptotic cells (Fig 2) . In contrast, increasing concentrations of DAPH resulted in fewer apoptotic cells following UVB irradiation. At concentrations of 10 or 30 mM DAPH, the irradiated HaCaT cells were identical in appearance to the unirradiated, matched control cells. Although HaCaT cells treated with 30 mM DAPH contained an increased number of intracellular vacuoles, these vacuoles were seen in both irradiated and unirradiated cells and thus were not in£uenced by UVB exposure. The inhibitory e¡ect of DAPH on UVB-induced apoptosis was con¢rmed by assaying for the activity of the apoptosis-induced enzyme caspase 3 ( Fig 3A) . The addition of DAPH to unirradiated HaCaT cells had no e¡ect on the induction of caspase 3 enzyme activity at any concentration of DAPH. Also, the addition of 1 mM DAPH did not in£uence the induction of apoptosis following a dose of 400 J per m 2 . Starting with 5 mM DAPH, however, there was a reciprocal decrease in caspase 3 speci¢c activity with increasing concentrations of DAPH. At 10 mM DAPH, the induction of caspase 3 speci¢c activity by UVB was reduced by 65%, and at 20 mM DAPH it was reduced by 78%. No adverse e¡ects on HaCaT cell morphology were observed using 20 mM DAPH.
UVB has been demonstrated to activate a variety of cell surface receptors in the absence of ligand (Sachsenmaier et al, 1994; Huang et al, 1996) . Therefore, the e¡ect of DAPH on the induction of UVB-induced apoptosis could be a generalized response to the ''capping'' phenomenon of cell surface receptors to UVB exposures. To examine this possibility, we used a small molecule inhibitor of the platelet-derived growth factor receptor (AG 1295) to see if the e¡ects we described for the erbB family receptors were speci¢c for DAPH or were more generalized to all tyrphostin-like molecules. In contrast to the results we describe for DAPH, AG 1295 had little to no e¡ect on UVB-induced apoptosis ( Fig 3B) . This result implies that the e¡ect of DAPH on UVB-induced apoptosis is speci¢c for the inhibition of erbB family receptors.
The tyrosine kinase activity of the erbB1 receptor can be speci¢cally inhibited by the drug AG 1478, whereas the erbB2 tyrosine kinase activity is suppressed by AG 825. If DAPH was able to suppress UVB-induced apoptosis via its ability to inhibit both erbB1 and erbB2 tyrosine kinase activities, then treating HaCaT cells with a combination of AG 1478 and AG 825 should yield similar results to DAPH. Treatment of HaCaT cells with AG 825 or AG 1478 individually resulted in a statistically insigni¢cant decrease in UVB-induced apoptosis ( Fig 3C) . In contrast, when HaCaT cells were UVB-irradiated and immediately treated with a combination of AG 825 and AG 1478, there was a protection of UVB-induced apoptosis similar to that in HaCaT cells that were treated with DAPH ( Fig 3C) . These data demonstrate that the simultaneous inhibition of both erbB1 and erbB2 tyrosine kinase activities leads to a suppression of UVB-induced apoptosis.
The inhibitory activity of DAPH was con¢rmed by analyzing the tyrosine phosphorylation status of erbB family receptors. HaCaT cells were treated with DAPH for 1 h, and subsequently erbB receptors were activated by treating the cells with EGF or UVB. As shown in Fig 4, treatment of HaCaT cells with either EGF or UVB led to the tyrosine phosphorylation of erbB family receptors. Due to the potential heterodimerization of erbB1 and erbB2 receptors and their similar apparent molecular weights, we cannot distinguish between erbB1 and erbB2 receptor activation in these assays. Pretreatment of the HaCaT cells with DAPH, however, completely inhibited the activation of erbB receptors following UVB irradiation and substantially reduced the phosphorylation of erbB receptors after the addition of EGF. These data con¢rmed the validity of using the drugs for their intended purposes.
Immobilization of the erbB1 receptor also suppresses UVBinduced apoptosis In order to con¢rm the results obtained using the pharmaceutical inhibitor DAPH, the activity of the erbB1 receptor was also inhibited through the use of neutralizing antibodies prior to UVB irradiation. As erbB2 homodimers have not been described to occur in keratinocytes, the use of a neutralizing antibody to erbB1 should suppress the activation of both erbB1 and erbB2 due to stearic hindrance of erbB1 mobility in the plasma membrane. This mechanical inhibition of the erbB1 receptor will e¡ectively inhibit both the erbB1 homodimers and erbB1:erbB2 heterodimers. Following treatment with the neutralizing antibody, the induction of caspase 3 activity by UVB was reduced by 70% ( Fig 5) , whereas irrelevant control antibodies had no e¡ect on UVB irradiation. UVB-induced apoptosis could also be suppressed by pretreating the HaCaT cells with neutralizing antibodies to erbB2. These data imply that erbB1:erbB2 heterodimers play a substantial role in UVB-induced apoptosis, but further studies are required to more completely delineate their relationship. Nevertheless, the inhibition of the erbB family receptors using two di¡erent mechanisms resulted in the suppression of UVB-induced apoptosis.
Suppression of apoptosis by DAPH is speci¢c for UVB Apoptosis can be induced in cells by a variety of di¡erent types of factors. To determine if the e¡ect of DAPH on UVB-induced apoptosis was a generalized response to apoptotic factors or if it was speci¢c for UVB, we used an alternative method to induce apoptosis in HaCaT cells. The tumor-necrosisfactor-related apoptosis-inducing ligand (TRAIL) has been shown to induce apoptosis in HaCaT cells through the activation of the death receptors DR4 and DR5 (Kothny-Wilkes et al, 1998; Southall et al, 2001) . HaCaT cells were treated with DAPH or the neutralizing anti-erbB1 antibody for 30 min prior to the addition of TRAIL. As seen in Fig 6, the addition of DAPH or the neutralizing antibody did not in£uence the induction of apoptosis by TRAIL. This suggests that the suppressive e¡ects of DAPH on the induction of apoptosis are limited to a protective response speci¢cally to UVB.
DISCUSSION
Exposure of HaCaT keratinocytes to UVB leads to the induction of apoptosis in a time-and dose-dependent manner, as measured Figure 4 . DAPH inhibits UVB-dependent erbB family receptor tyrosine phosphorylation. HaCaT cells were pretreated with 10 mM DAPH or left untreated for 60 min. The keratinocytes were then untreated, treated with 20 ng per ml EGF, or exposed to 400 J per m 2 of UVB. Cells were harvested 15 min following EGF or UVB treatment and cell lysates were assayed for erbB1 tyrosine phosphorylation. Equal loading of each cell lysate was con¢rmed by stripping each immunoblot and reprobing with erbB1-speci¢c antibodies. Figure 5 . Neutralizing antibodies to erbB1 and erbB2 suppress UVB-induced apoptosis. HaCaT cells were untreated or treated with 1 mg per ml neutralizing anti-erbB1 antibody, 1 mg per ml neutralizing anti-erbB2 antibody, or 1 mg per ml nonspeci¢c mouse IgG antibody for 30 min. The cells were then irradiated with a dose of 0 or 400 J per m 2 UVB. Cells were harvested 9 h following UVB irradiation and cell lysates were assayed for caspase 3 enzyme activity. Error bars signify ( þ /^) standard deviation and are representative of two to three di¡erent experiments. by increases in caspase 3 activity. Maximal induction of UVB-induced apoptosis in our experimental set-up occurred at a UVB dose of 400 J per m 2 , 9 h following irradiation. Treatment of Ha-CaT cells with either a pharmaceutical or a physical inhibitor of the erbB receptor family, however, could substantially inhibit the induction of apoptosis. The protective e¡ect on apoptosis by the erbB receptor inhibitors was speci¢c for UVB-induced apoptosis because the inhibitors had no e¡ect on the induction of apoptosis by TRAIL.
Although the exact pathway by which UVB induces apoptosis has yet to be elucidated, clues to the mechanism are beginning to emerge. It should not be too surprising that many of the pathways that have been identi¢ed are speci¢c for certain types of cells. For example, treatment of primary NHK with hepatocyte growth factor/scatter factor will abrogate UVB-induced apoptosis via phosphatidyl inositol-3 kinase and Akt activation (Mildner et al, 2002) . Even though the Akt pathway is functionally intact in HaCaT cells, hepatocyte growth factor/scatter factor does not provide any protection from UVB-induced apoptosis. There are some similarities in the UVB response of HaCaT cells and NHK, however. Inhibition of the stress-response mitogen-activated protein kinase p38 leads to a partial suppression of UVBinduced apoptosis in both NHK and HaCaT cells (Shimizu et al, 1999; Assefa et al, 2000) . 1 Similarly, the protective e¡ect of erbB family receptors on UVB-induced apoptosis in HaCaT cells that was presented in this paper can also be observed in NHK.
In NHK cells, the outcome of erbB family inhibitors and UVB was determined by the proliferative status of the keratinocytes. 2 If NHKs were actively proliferating, then inhibition of erbB receptors led to a protection from UVB-induced apoptosis. A similar phenomenon has been described for HaCaT cells where the overexpression of the immediate early gene product IEX-1 led to enhanced proliferative capacity and a corresponding increase in their sensitivity to UVB-induced apoptosis (Schilling et al, 2001) . Integrating these results suggests that actively proliferating HaCaT cells are more sensitive to UVB-induced apoptosis due to their increased mitogenic potential possibly involving increased erbB receptor activity.
Previous studies looking at erbB1 inhibitors have demonstrated that inhibition of erbB1 tyrosine kinase activity leads to a sensitization of UVB-induced apoptosis (Stoll et al, 1998; Peus et al, 2000; Jost et al, 2001a) . These results appear to be in contrast to the data presented in this paper, which describe a protective e¡ect of erbB receptor inhibition of UVB-induced apoptosis. It has also been reported that inhibitors of cellular tyrosine kinase activity in HaCaT cells will prevent UVB-induced apoptosis (Fukunaga et al, 2001) . This dissimilitude of results can be resolved by the di¡erence in the inhibitors used in each of the studies. In this paper, a pharmaceutical inhibitor that inactivates both the erbB1 and erbB2 receptors was used. Previous studies describing a protective function for the erbB1 receptor have used highly speci¢c small molecules that speci¢cally inhibit the erbB1 receptor activity without a¡ecting erbB2 receptor activity. The importance of these results is evident as UVB has been reported to cause the tyrosine phosphorylation of both the erbB1 and erbB2 receptors. erbB1:erbB2 heterodimerization has been described in other epithelial cells and is known to alter erbB1 function (Muthuswamy et al, 1999; Zhang et al, 2002) . Hence, we hypothesize that the dual speci¢city of DAPH on erbB1 and erbB2 tyrosine kinase activity alters the response of the HaCaT cells to UVB irradiation in a manner that is distinctly di¡erent from inhibition of erbB1 alone.
The analysis of erbB receptor function in keratinocytes, and speci¢cally HaCaT cells, is only just beginning. Similar to NHKs, HaCaT cells uniformly express the erbB1, erbB2, and erbB3 family members (Marques et al, 1999) . Following ligand binding, heterodimerization of all combinations of these three receptors has been described. It is still unclear, however, what the consequences of heterodimerization are. Heterodimerization of erb-B1:erbB2 can lead to changes in cellular localization, substrate interactions, and receptor stability compared to erbB1 homodimers. For instance, Zhang et al (2002) have shown that erbB1 homodimers lead to raf recruitment to the cell membrane and raf activation, followed by rapid dissociation of raf and erbB1 from the membrane. In contrast, erbB1:erbB2 heterodimers also lead to raf membrane recruitment and activation, but raf and the erbB receptors are maintained at the cell surface. Interestingly, we have preliminary evidence that UVB activation of erbB receptors remain cell surface associated and remain activated for extended periods of time (personal communication). Therefore, we are actively pursuing the possibility of UVB-induced heterodimerization of erbB1 and erbB2.
In conclusion, we have presented unique data that suggest that the inhibition of the erbB family of tyrosine kinase receptors protects HaCaT cells from UVB-induced apoptosis. We further propose that both the erbB1 and erbB2 receptor tyrosine kinase activity must be inactivated to observe the inhibition of UVBinduced apoptosis and that these results have implications for UVB exposure of actively proliferating keratinocytes in the epidermis.
The HaCaT cell line was kindly provided by Dr. Petra Boukamp. We would like to thank Drs Je¡rey Travers and Michael Southall for their helpful discussions and insightful suggestions on this project. This work was supported in part by a grant from the National Institutes of Health (R01ES11155 to DFS). Figure 6 . The role of erbB family receptors in apoptosis is speci¢c for UVB. HaCaT cells were untreated, treated with 10 mM DAPH, or treated with 1 mg per ml neutralizing anti-erbB1 antibody for 30 min. The cells were then irradiated with a dose of 400 J per m 2 UVB or treated with 40 ng per ml TRAIL. Cells were harvested 9 h following the induction of apoptosis and cell lysates were assayed for caspase 3 enzyme activity. Error bars signify ( þ /^) standard deviation and are representative of two or three di¡erent experiments.
